Clinical Trials
Find a trial by searching the Clinical Trial Databases
- ClinicalTrials.gov a resource provided by the U.S. National Library of Medicine that lists trials across 207 countries.
- International Clinical Trials Registry Platform hosted by the World Health Organisation
- EU Clinical Trials Register lists trials based in the European Union
- UK Clinical Trials Gateway for UK specific trials
- ANZGOG trials registered on the ANZCTR database for Australia and New Zealand
- Canadian Cancer Trials Canadian trials
- ISRCTN an international registry of clinical trials
A selection of clinical trials accepting women with low grade serous ovarian cancer
- Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian or Primary Peritoneal Cancer
- Ribociclib and Letrozole Treatment in Ovarian Cancer
- Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
- A Study of Onapristone ER in Low Grade Serous Ovarian Cancer and Other Progesterone Receptor Positive Gynecologic Cancers
- A Study Combining the M3814 Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Patients
- Phase I Trial of VS-6063 and RO5126766. (FRAME)
- Data Collection for Patients with Low Grade Ovarian Carcinoma
- Selumetinib and Olaparib in Solid Tumors
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer (MITO 22)
- Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in People With Metastatic Cancer
- Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies
- Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations
- A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Subjects With Advanced Solid Tumours
- Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer
- A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
- A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Patients With Advanced Solid Tumors
Cure Our Ovarian Cancer is not directly affiliated with any of the above databases or clinical trials. Clinical trials may have unique risks and unknown benefits which the clinical trial researchers and your doctor can help you understand.